Health

An oral antiviral drug from Korea may be a problem solver for COVID-19

SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that Dr.Jin-Ho Choi, a Chief Scientist of its major shareholding bio tech company CNPharm and Chair Professor at Dankook University, presented the study titled 'COVID-19 Game Changer Drug – a novel orga...

2021-05-13 16:37 2237

Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India

BEIJING, May 13, 2021 /PRNewswire/ -- Beijing Time May 10, 2021 — Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) and Shenzhen Pregene Biopharma Co., Ltd. today announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic ofInd...

2021-05-13 15:21 1839

Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance

TOKYO, May 12, 2021 /PRNewswire/ -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO:Hisashi Ietsugu) and ThinkCyte, Inc. (HQ: Bunkyo-ku, Tokyo, Japan; CEO: Waichiro Katsuda) announced today the signing of joint development and investment agreements duringMay 2021 for the commercializatio...

2021-05-12 22:00 2061

VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update

* Secured strongest-ever balance sheet with approximately $33.1 million in cash * Strengthened the Company's leadership team to drive commercial focus * Expanded the Company's intellectual property portfolio * Initiated production of product components at scale at the Company's Silver One ...

2021-05-12 04:10 6097

Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals

SYDNEY, May 11, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment ofShaemus Gleason as Executive Vice President U.S. Operations as the company expands its presence, clinica...

2021-05-11 21:04 2109

New Global Addiction Recovery and Overdose Prevention App

BETTER App Available for Download TODAY VANCOUVER, May 11, 2021 /PRNewswire/ -- A new mobile app has been developed to connect people around the world who are seeking recovery from addiction with a support community that wants to help - potentially saving lives.

2021-05-11 19:00 1462

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer

SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appoin...

2021-05-11 04:01 2846

PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...

2021-05-10 20:00 1801

Bionomics BNC210 Expansion into Social Anxiety Disorder

* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...

2021-05-10 18:00 3670

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...

2021-05-10 08:13 1784

Daewoong showed improved performance both sales and earnings in Q1

* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...

2021-05-07 21:00 5168

Waterdrop Inc. Announces Pricing of Initial Public Offering

BEIJING, May 7, 2021 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, today announced the pricing of its initial public offering ("IPO") of 30,000,000 American depositary shar...

2021-05-07 18:00 5174

HanAll Biopharma Reports First Quarter 2021 Financial Results

* Q1'21 sales of KRW 27.8 billion increased 26% compared to Q1'20 * Q1'21 operating profit of KRW 5.4 billion increased 80% compared to Q1'20 * Q1'21 operating margin of 19%, up from 14% in Q1'20 * Better-than-expected sales and operating profit are largely due to an increase of R&D revenue...

2021-05-06 21:00 4722

China Jo-Jo Drugstores Hosts Reception for Provincial Government Officials

HANGZHOU, China, May 6, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or "the Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the C...

2021-05-06 20:30 3472

VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update

AUSTIN, Texas, May 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onWednesday May 12, at 8:00 a.m. Eastern time to discuss its financial and operating results for the first quarter of 2021, in addition to providing a bu...

2021-05-06 20:15 3838

VNTC Develops the World's First Hybrid Scoliosis Brace - Spinamic

* From a rigid to hybrid brace, Spinamic setting a new trend for scoliosis bracing * "A new treatment alternative for scoliosis patients" SEOUL, South Korea, May 5, 2021 /PRNewswire/ -- VNTC, a MedTech company, has developed Spinamic, the world's first vest-like wearable hybrid scoliosis brac...

2021-05-06 00:00 1777

Carmine Therapeutics appoints Don Haut as CEO

CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced thatDon Haut, PhD has been appointedas its Chief Executive Officer, and member of the Board of Directors. Founded and incubated by EVX Ventures, Carmine is developing ne...

2021-05-05 21:00 2330

Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products

SYDNEY, May 4, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has received a response from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) appl...

2021-05-04 21:08 2088

Zepp Health Corp. to Report First Quarter 2021 Financial Results on May 13, 2021

BEIJING, May 4, 2021 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter of 2021 unaudited financial results before the marke...

2021-05-04 19:00 5598

HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring

TAIPEI, May 3, 2021 /PRNewswire/ -- HCmed today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop CSL Behring's plasma derived immunoglobulin administered via HCmed's new generation vibrating-mesh nebulizing device (CSL787). ...

2021-05-04 10:00 2043
1 ... 293294295296297298299 ... 313

Week's Top Stories